XYNI is now ready to reverse long. I analyze this because ZYXI has dropped
from overvalued and overbought through the fair value zone into undervalued
territory in three trading days by viewing the anchored VWAP bands and the
volume profile, The mean VWAP and POC line are confluent at 7.25. This is the
logical first target. The MACD lines are negative 4X the...
Nascent Biotech is reportedly closing in on phase I trial completion. I am interested to see if it pulls back and how it interacts with the moving averages.
www.nascentbiotech.com
I believe that CRSP (Crispr Therapeutics) is about to undergo a severe correction soon.
I scaled into this stock during the latter part of 2022 and the first part of 2023 and it is up nearly 70% and has generated about 40% of pure alpha for me relative to the SPX.
So this has been an amazing performer for my total portfolio.
I believe this run may be nearing a...
GLSI weekly demand level. A different idea from Fx and crypto, In this case a biotech stock for a volatile portfolio. Price at a weekly demand level with upside potential of 43% and a risk profile of 3.4R
FLMD had earnings in May with positive earnings beating the expectation of analysts that
it would continue to lose quarter after quarter. Investors and traders have reacted with a
80% run-up in the month after those earnings. On the 30-minute chart besides the consistent
uptrend with minor corrections, what stands out for me is the increasing volumes...
Based on Phase 2 data evaluation we could expect a positive outcome. Information sound good so far. THese kind of news often cause a wild rally on the day. Maybe two days. But generally they dont last long. Depends on the news of course.
But I would expect a pop on this on monday or tuesday. Maybe interesting for a short trade.
AUTL on the one-hour chart had a spontaneous parabolic move without a catalyst as best as
I can tell. Earnings ten days ago were decent but nothing special. AUTL as a biotech firm is
losing cash just not as much as analysts predicted. In the parabolic move very few shares
were traded between $2.00 and $2.40 as per the volume profile Overall a massive volume...
Biotech stocks can make huge moves, and this one is no exception.
TGTX more than doubled in a month and is showing no signs of slowing down.
Slower-trending, blue chip stocks tend to ride their 50-day moving average (red line on chart) on the way up.
Stronger stocks tend to hold their 21-day moving average (blue line).
But with high-flying honey badger stocks...
VYNE had a favorable earnings report last week. Fundamentally, analysts predict ( linked)
approximately a doubling of the shart price in the next year. Like many low share priced
biotechnology stocks the price is based on perceived future earnings which can be affected
by favorable FDA process, or well-received research at industry conferences and changing...
BlueBird Bio / BLUE had an earnigns report this past week showing earnings for the firat time
but revenue was far below analyst's projections. Price has appreciated 40% in the 4 weeks
since earnings which is about 500% annualized. GO BLUE.
On the daily chart, price was above VWAP and consolidating much of last fall then dropped
this YTD until the earnings...
#CathieWood
Baught this stock...I analyzed it....and …...well....I would do exact the opposite......
But why?
Technical Analysis
Let forget eveything you know about technical analysis, and let together tell this story....logically..
At
76-71 USD AGGRESSIVE SELLERS FORCED THE PICE DOWN
29,72 USD BUYERS DEFENDED THIS Area(ZONE) as well the sellers took...
MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under
the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into
earnings tomorrow. MRNA needs to show something good otherwise it will break through the
demand zone and keep going down.
This is a risky earnings play betting that...
On the 4H Chart LABU is trending up since March 27th. Last week there was a small pullback which was met with more buying activity.
On the volume indicator, the volume now is approximately 10X day by day compared with March's averages. It is this buying that is driving
the bullish momentum. Small-cap speculative biotech companies are in a growth mode right...
Hi Dude
from now on i am going to scrutinize Canada Stock market Shares
for This post I Analyze MDMA Share
as Depicted in picture i suggest:
Entry:0.295
SL:0.245
TP= 1:7 but dont hurry and wait for breaking orange trendline
if you like please support by comment and share
GOSS is a biotechnology penny stock without earnings valued based on future earnings
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line of the long-range volume profile. The RSI indicator is
now...
